In the AWARD 11 trial, patients using semaglutide (1 mg weekly) achieved greater weight reduction than those using dulaglutide (3 mg weekly), with a mean difference of approximately 0.24% points
We understand that each individuals progress is unique, so we tailor the weekly injection doses based on the patients journey, ensuring that their weight loss goals are not only met but exceeded
The percentage of GLP-1 cells positive for Snap25 was evaluated on digital images of 5 tissue sections from 3 different mice
The expression levels of chemerin and CMKLR1 are increased in degenerative NP tissues, especially those of obese individuals (48)
PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis
Zuberbier T, Ensina LF, Gimenez-Arnau A, et al